Status:
UNKNOWN
Cognitive and Behavioral Therapy of Anxiety in Williams Syndrome
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Fondation Jérôme Lejeune
association autour des Williams
Conditions:
Williams Syndrome
Anxiety
Eligibility:
All Genders
18+ years
Brief Summary
Patients with Williams-Beuren syndrome are eight times more likely to suffer from anxiety compared to the general population. Few therapeutic solutions are proposed to these patients. The objective of...
Detailed Description
Most studies agree that anxiety disorders are more frequent in people with intellectual disabilities that in the general population. Williams syndrome (WS) is a rare disease, associated with an anxiet...
Eligibility Criteria
Inclusion
- Diagnosis of Williams Syndrome
- Complaint about anxiety
- 18 years old and more
- Score of 7 or more at the CELF-4 (it is a scale assessing the language)
- informed consent signed
Exclusion
- Scoring less than 7 at the CELF-4
- Hearing impairment
- Visual impairment
Key Trial Info
Start Date :
August 29 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 29 2021
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT03827525
Start Date
August 29 2019
End Date
April 29 2021
Last Update
October 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arnaud de villeneuve Hospital
Montpellier, Hérault, France, 34295